These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 15837318
1. Solid-phase synthesis and antibacterial evaluations of N-demethylvancomycin derivatives. Yao NH, Liu G, He WY, Niu C, Carlson JR, Lam KS. Bioorg Med Chem Lett; 2005 May 02; 15(9):2325-9. PubMed ID: 15837318 [Abstract] [Full Text] [Related]
2. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria. Chang J, Zhang SJ, Jiang YW, Xu L, Yu JM, Zhou WJ, Sun X. ChemMedChem; 2013 Jun 02; 8(6):976-84. PubMed ID: 23576378 [Abstract] [Full Text] [Related]
3. Synthesis and antibacterial activity against Clostridium difficile of novel demethylvancomycin derivatives. Zhang SJ, Yang Q, Xu L, Chang J, Sun X. Bioorg Med Chem Lett; 2012 Aug 01; 22(15):4942-5. PubMed ID: 22765891 [Abstract] [Full Text] [Related]
5. N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. II. Antibacterial activity of N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. Plattner JJ, Chu D, Mirchink EP, Isakova EB, Preobrazhenskaya MN, Olsufyeva EN, Miroshnikova OV, Printsevskaya SS. J Antibiot (Tokyo); 2007 Apr 01; 60(4):245-50. PubMed ID: 17456974 [Abstract] [Full Text] [Related]
6. Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria. Nakama Y, Yoshida O, Yoda M, Araki K, Sawada Y, Nakamura J, Xu S, Miura K, Maki H, Arimoto H. J Med Chem; 2010 Mar 25; 53(6):2528-33. PubMed ID: 20180534 [Abstract] [Full Text] [Related]
7. Synthesis and antibacterial activity of O-substituted nocathiacin I derivatives. Naidu BN, Sorenson ME, Hudyma T, Zheng X, Zhang Y, Bronson JJ, Pucci MJ, Clark JM, Ueda Y. Bioorg Med Chem Lett; 2004 Jul 16; 14(14):3743-6. PubMed ID: 15203154 [Abstract] [Full Text] [Related]
8. Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers. Griffin JH, Linsell MS, Nodwell MB, Chen Q, Pace JL, Quast KL, Krause KM, Farrington L, Wu TX, Higgins DL, Jenkins TE, Christensen BG, Judice JK. J Am Chem Soc; 2003 May 28; 125(21):6517-31. PubMed ID: 12785792 [Abstract] [Full Text] [Related]
9. Synthesis and antibacterial activity of nocathiacin I analogues. Naidu BN, Sorenson ME, Matiskella JD, Li W, Sausker JB, Zhang Y, Connolly TP, Lam KS, Bronson JJ, Pucci MJ, Yang H, Ueda Y. Bioorg Med Chem Lett; 2006 Jul 01; 16(13):3545-9. PubMed ID: 16621551 [Abstract] [Full Text] [Related]
10. Antibiotic activities and affinities for bacterial cell wall analogue of N-demethylvancomycin and its derivatives. Yan H, Qi D, Cheng X, Song Z, Li W, He B. J Antibiot (Tokyo); 1998 Aug 01; 51(8):750-6. PubMed ID: 9766467 [Abstract] [Full Text] [Related]
11. Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria. Lu J, Yoshida O, Hayashi S, Arimoto H. Chem Commun (Camb); 2007 Jan 21; (3):251-3. PubMed ID: 17299629 [Abstract] [Full Text] [Related]
12. Synthesis and antibacterial activities of chiral 1,3-oxazinan-2-one derivatives. Wang G, Ella-Menye JR, Sharma V. Bioorg Med Chem Lett; 2006 Apr 15; 16(8):2177-81. PubMed ID: 16495055 [Abstract] [Full Text] [Related]
13. Synthesis and structure-antibacterial activity relationship investigation of isomeric 2,3,5-substituted perhydropyrrolo[3,4-d]isoxazole-4,6-diones. Agirbas H, Guner S, Budak F, Keceli S, Kandemirli F, Shvets N, Kovalishyn V, Dimoglo A. Bioorg Med Chem; 2007 Mar 15; 15(6):2322-33. PubMed ID: 17276071 [Abstract] [Full Text] [Related]
14. Synthesis of caprazamycin analogues and their structure--activity relationship for antibacterial activity. Hirano S, Ichikawa S, Matsuda A. J Org Chem; 2008 Jan 18; 73(2):569-77. PubMed ID: 18092805 [Abstract] [Full Text] [Related]
15. Elucidation of the active conformation of vancomycin dimers with antibacterial activity against vancomycin-resistant bacteria. Nakamura J, Yamashiro H, Hayashi S, Yamamoto M, Miura K, Xu S, Doi T, Maki H, Yoshida O, Arimoto H. Chemistry; 2012 Oct 01; 18(40):12681-9. PubMed ID: 22915313 [Abstract] [Full Text] [Related]
16. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE). Jia Y, Bois-Choussy M, Malabarba A, Brunati C, Zhu J. J Antibiot (Tokyo); 2006 Sep 01; 59(9):543-52. PubMed ID: 17136887 [Abstract] [Full Text] [Related]
18. [Synthesis and in vitro antibacterial activities of new 3,5-disubstituted oxazolidinone compounds]. Meng QG, Wang Q, Liu J. Yao Xue Xue Bao; 2003 Oct 01; 38(10):754-9. PubMed ID: 14730898 [Abstract] [Full Text] [Related]
19. Nocathiacin I analogues: synthesis, in vitro and in vivo biological activity of novel semi-synthetic thiazolyl peptide antibiotics. Naidu BN, Sorenson ME, Zhang Y, Kim OK, Matiskella JD, Wichtowski JA, Connolly TP, Li W, Lam KS, Bronson JJ, Pucci MJ, Clark JM, Ueda Y. Bioorg Med Chem Lett; 2004 Nov 15; 14(22):5573-7. PubMed ID: 15482927 [Abstract] [Full Text] [Related]
20. [Recent advances in the study of synthesis and activity of vancomycin derivatives]. Chen YY, Liu G. Yao Xue Xue Bao; 2007 May 15; 42(5):463-9. PubMed ID: 17703765 [Abstract] [Full Text] [Related] Page: [Next] [New Search]